New Warning on Johnson & Johnson COVID-19 Vaccine:
SCOOP: FDA expected to announce new warning on Johnson & Johnson vaccine linked to rare autoimmune disorder, Guillain-Barre syndrome. About 100 reports of GBS detected after 12.8 million doses. Most people fully recover from GBS. @lauriemcginley2 + me. https://t.co/NHMHyGAzg0
— LenaSun (@bylenasun) July 12, 2021
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user’s social media account and Today News 24 Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of Today News 24, also Today News 24 does not assume any responsibility or liability for the same.)
articleid = $(this).attr('data-articleid'); articleupdate = $(this).attr('data-articleupdate'); socially_title = $(this).attr('data-articletitle'); socially_url = $(this).attr('data-newurl'); emoji = $(this).attr('data-emoji');
emoji1 = $(this).prevAll(".socially_article_widget2").attr('data-emoji'); socially_url2 = $(this).prevAll(".socially_article_widget2").attr('data-newurl'); articleid1 = $(this).prevAll(".socially_article_widget2").attr('data-newid');
var top = window.pageYOffset; var distance = top - $(this).offset().top; var newhref = socially_url;
var scrollTop = $(window).scrollTop(); var top_of_element1 = jQuery(".socially_article").last().offset().top; //console.log("count: "+scrollTop+" "+top_of_element1); if((scrollTop 3000) && !working && currenthref != socially_url1){ working = true; currenthref = socially_url1; var infiniteScrollArticles="
"; //bottom sticky widget when scroll up at 1st article $(".bxslider").html(infiniteScrollArticles); var emoji2 = "FDA May Announce New Warning on Johnson & Johnson COVID-19 Vaccine Related to Guillain-Barré Syndrome, a Rare Autoimmune Disorder: Washington Post Report | ? Today News 24"; console.log("count1"); var newhref1 = "https://www.todaynews24.top/socially/world/fda-may-announce-new-warning-on-johnson-johnson-covid-19-vaccine-related-to-guillain-barre-syndrome-a-rare-autoimmune-disorder-washington-post-report-2634839.html"; $('h1:first').text("FDA May Announce New Warning on Johnson & Johnson COVID-19 Vaccine Related to Guillain-Barré Syndrome, a Rare Autoimmune Disorder: Washington Post Report"); $(document).find("title").text(emoji2) window.history.pushState("","","https://www.todaynews24.top/socially/world/fda-may-announce-new-warning-on-johnson-johnson-covid-19-vaccine-related-to-guillain-barre-syndrome-a-rare-autoimmune-disorder-washington-post-report-2634839.html"); gtag('config', 'UA-111635423-1', { 'page_path': newhref1.replace("https://"+window.location.hostname+"/", "")}); setTimeout(function(){ working=false; }, 400); return false; }
//console.log("distance "+distance+" && working"+working+" &¤thref:"+currenthref+" && newhref"+newhref+" && socially_url2"+socially_url2+" "+k); if(distance -900 && !working && newhref != socially_url2 && currenthref == newhref && typeof socially_url2 != 'undefined'){ newhref = socially_url2;
//bottom sticky widget when scroll up relatedArticleWidget = $('.bx'+articleid1).html(); $(".bxslider").html(relatedArticleWidget); currenthref = newhref; console.log("change url2"+newhref); working = true;
$('h1:first').text($(this).prevAll(".socially_article_widget2").attr('data-articletitle')); $('meta[property=og\:title]').attr('content', $(this).prevAll(".socially_article_widget2").attr('data-articletitle')); $('meta[property=og\:url]').attr('content', newhref); $(document).find("title").text($(this).prevAll(".socially_article_widget2").attr('data-articletitle')+' | '+emoji1+' Today News 24') window.history.pushState("","",newhref); gtag('config', 'UA-111635423-1', { 'page_path': newhref.replace("https://"+window.location.hostname+"/", "")}); self.COMSCORE && COMSCORE.beacon({ c1: "2", c2: "27040963" });
setTimeout(function(){ working=false; }, 500); return false; }else if (distance -450 && !working && currenthref != newhref) { working = true;
////bottom sticky widget when scroll down relatedArticleWidget = $('.bx'+articleid).html(); $(".bxslider").html(relatedArticleWidget); currenthref = newhref; console.log("change url1"+newhref); $('h1:first').text($(this).attr('data-title')); $('meta[property=og\:title]').attr('content', socially_title); $('meta[property=og\:url]').attr('content', newhref); $(document).find("title").text(socially_title +' | '+emoji+' Today News 24') window.history.pushState("","",newhref); //var res = newhref.replace("https://www.todaynews24.top/", ""); gtag('config', 'UA-111635423-1', { 'page_path': newhref.replace("https://"+window.location.hostname+"/", "")}); self.COMSCORE && COMSCORE.beacon({ c1: "2", c2: "27040963" }); setTimeout(function(){ working=false; }, 400); return false; } }); var bottom_of_screen = jQuery(window).scrollTop() + window.innerHeight; var top_of_element = jQuery(".container .article-footer").last().offset().top; if(bottom_of_screen > top_of_element && !visible){ visible = true; k=k+1; if(k==2 && false){ var dm_js = document.createElement('script'); dm_js.src="https://stfe.todaynews24.top/js/dm-ce.min.js?v=1.1"; dm_js.async="async"; document.body.appendChild(dm_js); } $.ajax({ method: "GET", url: "/larajax/live-socially-ajax/", data:{ curr_socially:articleid,curr_date:articleupdate,index:k }, dataType: 'json' }).done(function( data ) { $(".socially_article").append(data.html); $("img.lazyload").lazyload(); window.instgrm.Embeds.process(); var slotName = "div-gpt-ad-1560419575255-"+k; googletag.cmd.push(function() { var slot = googletag.defineSlot('/21682383758/latestly_728x90_btf1', [728, 90], slotName). addService(googletag.pubads()); googletag.display(slotName); googletag.pubads().refresh([slot]); }); googletag.cmd.push(function() { googletag.display('div-gpt-ad-1560419575255-'+k); }); var slotName = "div-gpt-ad-1568807958472-"+k; googletag.cmd.push(function() { var slot = googletag.defineSlot('/21682383758/728x90_Top', [728, 90], slotName). addService(googletag.pubads()); googletag.display(slotName); googletag.pubads().refresh([slot]); }); googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568807958472-'+k); });
loadAPI_Social_js()
var js_fb = document.createElement('script'); js_fb.src="https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v3.3&appId=224265671451116&autoLogAppEvents=1"; document.body.appendChild(js_fb);
//colombai try{ (function() { var cads = document.createElement("script"); cads.async = true; cads.type = "text/javascript"; cads.src = "https://static.clmbtech.com/ase/80185/3040/c1.js"; var node = document.getElementsByTagName("script")[0]; node.parentNode.insertBefore(cads, node); })(); }catch(e){} }); }else if(bottom_of_screen
//vdo (function(v,d,o,ai){ai=d.createElement('script');ai.defer=true;ai.async=true;ai.src=v.location.protocol+o;d.head.appendChild(ai);})(window, document, '//a.vdo.ai/core/latestly/vdo.ai.js');
//colombai try{ (function() { var cads = document.createElement("script"); cads.async = true; cads.type = "text/javascript"; cads.src = "https://static.clmbtech.com/ase/80185/3040/c1.js"; var node = document.getElementsByTagName("script")[0]; node.parentNode.insertBefore(cads, node); })(); }catch(e){}
} });